GYRE THERAPEUTICS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
GYRE THERAPEUTICS, INC. has filed 1,598 SEC EDGAR filings since 16 Dec 2002

SEC filing history

Showing 776-800 of 1,000 matching filings.

Per page
25
Current page
32
S-1/A File 333-216663

S-1/A

Filing date
31 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-82442

CATALYST BIOSCIENCES, INC. - AMENDMENT #5

Filing date
29 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-51173

CT ORDER filing

Filing date
22 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-216663

FORM S-1

Filing date
13 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

8-K

Filing date
08 Mar 2017
Reporting date
08 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-82442

AMENDMENT NO. 2 TO THE SCHEDULE 13G

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

FORM 8-K

Filing date
10 Feb 2017
Reporting date
10 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

8-K

Filing date
02 Feb 2017
Reporting date
02 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-51173

DEFINITIVE PROXY STATEMENT

Filing date
12 Jan 2017
Reporting date
02 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
06 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-51173

PRELIMINARY PROXY STATEMENT

Filing date
30 Dec 2016
Reporting date
30 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

8-K - PFIZER TERMINATION AGREEMENT

Filing date
14 Dec 2016
Reporting date
08 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

8-K - NASDAQ

Filing date
02 Dec 2016
Reporting date
29 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

8-K

Filing date
03 Nov 2016
Reporting date
03 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

8-K LADENBURG THALMANN PRESENTATION

Filing date
28 Sep 2016
Reporting date
27 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

8-K

Filing date
16 Sep 2016
Reporting date
14 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

8-K RODMAN & RENSHAW PRESENTATION

Filing date
14 Sep 2016
Reporting date
13 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-51173

CT ORDER filing

Filing date
12 Sep 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

FORM 8-K

Filing date
09 Sep 2016
Reporting date
03 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

FORM 8-K

Filing date
04 Aug 2016
Reporting date
04 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-212345

S-8

Filing date
30 Jun 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51173

8-K

Filing date
14 Jun 2016
Reporting date
09 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .